What are the major opportunities in the Thyroid Eye Disease (TED) market? What are the strategies for the Thyroid Eye Disease (TED) market?

For detailed insights on the major opportunities and strategies in the Thyroid Eye Disease (TED) market, Read More

How does the Thyroid Eye Disease (TED) market relate to the overall economy and other similar markets?

For detailed insights on the key dynamics influencing the Thyroid Eye Disease (TED) market growth and SWOT analysis of the Thyroid Eye Disease (TED) industry, Read More

For detailed insights on the mergers and acquisitions in the Thyroid Eye Disease (TED) industry,

What are the key dynamics influencing the Thyroid Eye Disease (TED) market growth? SWOT analysis of the Thyroid Eye Disease (TED) market. Read More

Thyroid Eye Disease (TED) Market Global Report 2026 Market Report Infographic Image

Published : March 2026

Pages : 175

Format : PDF

Delivery Time : 2-3 Business Days

Report Price : $4490.00

Thyroid Eye Disease (TED) Market Report 2026

Name: Thyroid Eye Disease (TED) Market Report 2026
Brand: The Business Research Company
Price: 4490.00 USD
Availability: InStock

Global Outlook – By Treatment Type (Medical, Surgical, Combination Of Medical And Surgical), By Disease Severity (Mild, Moderate, Severe), By Drug Type (Biologics, Small Molecules, Other Drug Types), By Route Of Administration (Oral, Intravenous, Subcutaneous), By End User (Hospitals, Clinics, Other End Users) - Market Size, Trends, And Global Forecast 2025-2034

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Purchase This Report Download Sample PDF

Item added to cart!

Thyroid Eye Disease (TED) Market Overview

• Thyroid Eye Disease (TED) market size has reached to $2.29 billion in 2025

• Expected to grow to $3.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%

• Growth Driver: Thyroid Disorders And Their Influence On The Market Dynamics

• Market Trend: Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment

• North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Thyroid Eye Disease (TED) Market?

Thyroid eye disease (TED), also known as Graves' Orbitopathy, is an autoimmune condition characterized by inflammation and swelling of the tissues around the eyes, often associated with thyroid disorders. TED can cause symptoms such as bulging eyes, double vision, and eye pain.

The main treatment types of thyroid eye disease (TED) are medical, surgical, and a combination of medical and surgical approaches. Medical treatment of thyroid eye disease (TED) typically involves the use of corticosteroids, immunosuppressive drugs, and biologic therapies to reduce inflammation, control symptoms, and prevent disease progression. It is tailored based on the disease severity, which can be classified into mild, moderate, and severe stages. Drugs used for treatment fall into different categories, including biologics, small molecules, and others. It is available in various routes of administration options, including oral, intravenous, and subcutaneous delivery methods and are used by several end users such as hospitals, clinics, and others.

Thyroid Eye Disease (TED) Market Global Report 2026 Market Report bar graph

What Is The Thyroid Eye Disease (TED) Market Size and Share 2026?

The thyroid eye disease (ted) market size has grown strongly in recent years. It will grow from $2.29 billion in 2025 to $2.44 billion in 2026 at a compound annual growth rate (CAGR) of 6.6%. The growth in the historic period can be attributed to increasing prevalence of autoimmune thyroid disorders, improved clinical recognition of ted symptoms, wider use of corticosteroid therapies, expansion of ophthalmology services, growing referral rates from endocrinology clinics.

What Is The Thyroid Eye Disease (TED) Market Growth Forecast?

The thyroid eye disease (ted) market size is expected to see strong growth in the next few years. It will grow to $3.12 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing adoption of novel biologics such as teprotumumab, rising investments in autoimmune disease research, expansion of minimally invasive surgical options, growing focus on quality-of-life outcomes, increasing demand for personalized ted therapies. Major trends in the forecast period include increasing adoption of targeted biologic therapies, rising use of combination treatment approaches, growing focus on early disease intervention, expansion of specialized ophthalmic care, enhanced patient-centered treatment models.

Book your 30 minutes free consultation with our research experts

Global Thyroid Eye Disease (TED) Market Segmentation

1) By Treatment Type: Medical, Surgical, Combination Of Medical And Surgical

2) By Disease Severity: Mild, Moderate, Severe

3) By Drug Type: Biologics, Small Molecules, Other Drug Types

4) By Route Of Administration: Oral, Intravenous, Subcutaneous

5) By End User: Hospitals, Clinics, Other End Users

Subsegments:

1) By Medical: Corticosteroids, Teprotumumab, Antithyroid Medications

2) By Surgical: Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

3) By Combination Of Medical and Surgical: Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery

What Is The Driver Of The Thyroid Eye Disease (TED) Market?

Rising thyroid disorders are expected to propel the growth of the thyroid eye disease (TED) market going forward. Thyroid disorders are medical conditions that affect the function of the thyroid gland, leading to imbalances in hormone production and resulting in conditions such as hypothyroidism, hyperthyroidism, goiter, and thyroid eye disease. Rising thyroid disorders are driven by factors such as increased iodine intake, autoimmune conditions, genetic predisposition, and greater awareness leading to improved diagnostic rates. Thyroid Eye Disease (TED) contributes to the rise in thyroid disorder cases, as it is a common and serious complication of Graves' disease, increasing the overall burden and awareness of thyroid-related conditions. For instance, in May 2024, according to the Canadian Cancer Society, a Canada-based non-profit, community-based organization, in 2024, an estimated 6,600 new cases of thyroid cancer are expected to be diagnosed in Canada, with approximately 280 fatalities projected. Therefore, rising thyroid disorders are driving the growth of the thyroid eye disease (TED) industry.

Key Players In The Global Thyroid Eye Disease (TED) Market

Major companies operating in the thyroid eye disease (ted) market are Viridian Therapeutics Inc, Tourmaline Bio Inc, Sling Therapeutics Inc, Immunovant Inc, Hoffmann-La Roche AG, H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Sanofi SA, Alexion Pharmaceuticals Inc, Septerna Corporation

Global Thyroid Eye Disease (TED) Market Trends and Insights

Major companies operating in the thyroid eye disease (TED) market are focusing on innovative products, such as monoclonal antibody therapies, to develop more effective, targeted treatments that reduce inflammation, improve proptosis, and enhance overall patient outcomes. Monoclonal antibody therapies are treatments that use laboratory-made antibodies designed to mimic the immune system’s ability to target and neutralize specific pathogens or abnormal cells. For instance, in September 2024, Amgen Inc., a US-based biotechnology company, announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved TEPEZZA (teprotumumab) for treating active thyroid eye disease (TED), a rare and potentially vision-threatening autoimmune disorder. It is the first and only FDA-approved therapy specifically for TED, offering a targeted treatment that helps reduce inflammation, swelling, and other debilitating symptoms associated with the disease. This approval is particularly important for patients in Japan, as it provides a new, effective option to manage TED, a rare and progressive condition that causes debilitating eye bulging, vision problems, and eye pain.

Need data on a specific region in this market?

Request Regional Data

What Are Latest Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market?

In October 2023, Amgen Inc., a US-based biopharmaceutical company, acquired Horizon Therapeutics plc for an undisclosed amount. With this acquisition, Amgen aims to strengthen its rare and inflammatory disease portfolio by leveraging Horizon’s key therapies, expanding global reach, and accelerating innovation for long-term growth. Horizon Therapeutics plc is an Ireland-based company that specializes in rare autoimmune and inflammatory diseases.

Regional Outlook

North America was the largest region in the thyroid eye disease (TED) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

What Defines the Thyroid Eye Disease (TED) Market?

The thyroid eye disease (TED) market includes revenues earned by entities by providing services such as diagnosis services, pharmaceutical services, surgical services, support, and counseling services and related products including thyroid hormone replacement therapy, immunosuppressive drugs, surgical products, and devices. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

What Key Data and Analysis Are Included in the Thyroid Eye Disease (TED) Market Report 2026?

The thyroid eye disease (ted) market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the thyroid eye disease (ted) industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.

Author : Abdul Wasay

Thyroid Eye Disease (TED) Market Report Forecast Analysis

Report Attribute	Details
Market Size Value In 2026	$2.44 billion
Revenue Forecast In 2035	$3.12 billion
Growth Rate	CAGR of 6.6% from 2026 to 2035
Base Year For Estimation	2025
Actual Estimates/Historical Data	2020-2025
Forecast Period	2026 - 2030 - 2035
Market Representation	Revenue in USD Billion and CAGR from 2026 to 2035
Segments Covered	Treatment Type, Disease Severity, Drug Type, Route Of Administration, End User
Regional Scope	Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Country Scope	The countries covered in the report are Australia, Brazil, China, France, Germany, India, ...
Key Companies Profiled	Viridian Therapeutics Inc, Tourmaline Bio Inc, Sling Therapeutics Inc, Immunovant Inc, Hoffmann-La Roche AG, H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Sanofi SA, Alexion Pharmaceuticals Inc, Septerna Corporation
Customization Scope	Request for Customization
Pricing And Purchase Options	Explore Purchase Options

1. Executive Summary

1.1. Key Market Insights (2020-2035)

1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots

1.3. Major Factors Driving the Market

1.4. Top Three Trends Shaping the Market

2. Thyroid Eye Disease (TED) Market Characteristics

2.1. Market Definition & Scope

2.2. Market Segmentations

2.3. Overview of Key Products and Services

2.4. Global Thyroid Eye Disease (TED) Market Attractiveness Scoring And Analysis

2.4.1. Overview of Market Attractiveness Framework

2.4.2. Quantitative Scoring Methodology

2.4.3. Factor-Wise Evaluation

Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation

2.4.5. Strategic Implications and Recommendations

3. Thyroid Eye Disease (TED) Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem

3.2. List Of Key Raw Materials, Resources & Suppliers

3.3. List Of Major Distributors and Channel Partners

3.4. List Of Major End Users

4. Global Thyroid Eye Disease (TED) Market Trends And Strategies

4.1. Key Technologies & Future Trends

4.1.1 Biotechnology, Genomics & Precision Medicine

4.1.2 Artificial Intelligence & Autonomous Intelligence

4.1.3 Digitalization, Cloud, Big Data & Cybersecurity

4.1.4 Sustainability, Climate Tech & Circular Economy

4.1.5 Industry 4.0 & Intelligent Manufacturing

4.2. Major Trends

4.2.1 Increasing Adoption Of Targeted Biologic Therapies

4.2.2 Rising Use Of Combination Treatment Approaches

4.2.3 Growing Focus On Early Disease Intervention

4.2.4 Expansion Of Specialized Ophthalmic Care

4.2.5 Enhanced Patient-Centered Treatment Models

5. Thyroid Eye Disease (TED) Market Analysis Of End Use Industries

5.1 Hospitals

5.2 Specialty Eye Clinics

5.3 Ophthalmology Centers

5.4 Endocrinology Clinics

5.5 Ambulatory Surgical Centers

6. Thyroid Eye Disease (TED) Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Thyroid Eye Disease (TED) Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Thyroid Eye Disease (TED) PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)

7.2. Global Thyroid Eye Disease (TED) Market Size, Comparisons And Growth Rate Analysis

7.3. Global Thyroid Eye Disease (TED) Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)

7.4. Global Thyroid Eye Disease (TED) Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Thyroid Eye Disease (TED) Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)

8.2. Methodology and Assumptions

8.3. Global Total Addressable Market (TAM) Estimation

8.4. TAM vs. Current Market Size Analysis

8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Thyroid Eye Disease (TED) Market Segmentation

9.1. Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Medical, Surgical, Combination Of Medical And Surgical

9.2. Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Mild, Moderate, Severe

9.3. Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Biologics, Small Molecules, Other Drug Types

9.4. Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Oral, Intravenous, Subcutaneous

9.5. Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Hospitals, Clinics, Other End Users

9.6. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Corticosteroids, Teprotumumab, Antithyroid Medications

9.7. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Orbital Decompression Surgery, Eyelid Surgery, Strabismus Surgery

9.8. Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical and Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Combination of Corticosteroids and Orbital Decompression, Combination of Teprotumumab and Eyelid Surgery

10. Thyroid Eye Disease (TED) Market Regional And Country Analysis

10.1. Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

10.2. Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Thyroid Eye Disease (TED) Market

11.1. Asia-Pacific Thyroid Eye Disease (TED) Market Overview

Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

11.2. Asia-Pacific Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Thyroid Eye Disease (TED) Market

12.1. China Thyroid Eye Disease (TED) Market Overview

Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

12.2. China Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Thyroid Eye Disease (TED) Market

13.1. India Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Thyroid Eye Disease (TED) Market

14.1. Japan Thyroid Eye Disease (TED) Market Overview

14.2. Japan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Thyroid Eye Disease (TED) Market

15.1. Australia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Thyroid Eye Disease (TED) Market

16.1. Indonesia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Thyroid Eye Disease (TED) Market

17.1. South Korea Thyroid Eye Disease (TED) Market Overview

17.2. South Korea Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Thyroid Eye Disease (TED) Market

18.1. Taiwan Thyroid Eye Disease (TED) Market Overview

18.2. Taiwan Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Thyroid Eye Disease (TED) Market

19.1. South East Asia Thyroid Eye Disease (TED) Market Overview

19.2. South East Asia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Thyroid Eye Disease (TED) Market

20.1. Western Europe Thyroid Eye Disease (TED) Market Overview

20.2. Western Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Thyroid Eye Disease (TED) Market

21.1. UK Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Thyroid Eye Disease (TED) Market

22.1. Germany Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Thyroid Eye Disease (TED) Market

23.1. France Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Thyroid Eye Disease (TED) Market

24.1. Italy Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Thyroid Eye Disease (TED) Market

25.1. Spain Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Thyroid Eye Disease (TED) Market

26.1. Eastern Europe Thyroid Eye Disease (TED) Market Overview

26.2. Eastern Europe Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Thyroid Eye Disease (TED) Market

27.1. Russia Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Thyroid Eye Disease (TED) Market

28.1. North America Thyroid Eye Disease (TED) Market Overview

28.2. North America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Thyroid Eye Disease (TED) Market

29.1. USA Thyroid Eye Disease (TED) Market Overview

29.2. USA Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Thyroid Eye Disease (TED) Market

30.1. Canada Thyroid Eye Disease (TED) Market Overview

30.2. Canada Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Thyroid Eye Disease (TED) Market

31.1. South America Thyroid Eye Disease (TED) Market Overview

31.2. South America Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Thyroid Eye Disease (TED) Market

32.1. Brazil Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Thyroid Eye Disease (TED) Market

33.1. Middle East Thyroid Eye Disease (TED) Market Overview

33.2. Middle East Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Thyroid Eye Disease (TED) Market

34.1. Africa Thyroid Eye Disease (TED) Market Overview

34.2. Africa Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Segmentation By Disease Severity, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Thyroid Eye Disease (TED) Market Regulatory and Investment Landscape

36. Thyroid Eye Disease (TED) Market Competitive Landscape And Company Profiles

36.1. Thyroid Eye Disease (TED) Market Competitive Landscape And Market Share 2024

36.1.1. Top 10 Companies (Ranked by revenue/share)

36.2. Thyroid Eye Disease (TED) Market - Company Scoring Matrix

36.2.1. Market Revenues

36.2.2. Product Innovation Score

36.2.3. Brand Recognition

36.3. Thyroid Eye Disease (TED) Market Company Profiles

36.3.1. Viridian Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.2. Tourmaline Bio Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.3. Sling Therapeutics Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.4. Immunovant Inc Overview, Products and Services, Strategy and Financial Analysis

36.3.5. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis

37. Thyroid Eye Disease (TED) Market Other Major And Innovative Companies

H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc

38. Global Thyroid Eye Disease (TED) Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Thyroid Eye Disease (TED) Market

40. Thyroid Eye Disease (TED) Market High Potential Countries, Segments and Strategies

40.1 Thyroid Eye Disease (TED) Market In 2030 - Countries Offering Most New Opportunities

40.2 Thyroid Eye Disease (TED) Market In 2030 - Segments Offering Most New Opportunities

40.3 Thyroid Eye Disease (TED) Market In 2030 - Growth Strategies

40.3.1 Market Trend Based Strategies

40.3.2 Competitor Strategies

41. Appendix

41.1. Abbreviations

41.2. Currencies

41.3. Historic And Forecast Inflation Rates

41.4. Research Inquiries

41.5. The Business Research Company

41.6. Copyright And Disclaimer

List Of Tables

Table 1: Global Thyroid Eye Disease (TED) Market, Overview Of Key Products - Product Examples

Table 2: Global Thyroid Eye Disease (TED) Market Attractiveness, Factor-Wise Evaluation

Table 3: Global Thyroid Eye Disease (TED) Market, Supply Chain Analysis

Table 4: Global Thyroid Eye Disease (TED) Market, Major Raw Material Providers

Table 5: Global Thyroid Eye Disease (TED) Market, Major Resource Providers

Table 6: Global Thyroid Eye Disease (TED) Market, Major Manufacturers (Suppliers)

Table 7: Global Thyroid Eye Disease (TED) Market, Major Distributors And Channel Partners

Table 8: Global Thyroid Eye Disease (TED) Market, Key Technologies & Future Trends

Table 9: Global Thyroid Eye Disease (TED) Market, Major Trends

Table 10: Global Thyroid Eye Disease (TED) Market, Major End Users

Table 11: Global Thyroid Eye Disease (TED) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Table 12: Global Thyroid Eye Disease (TED) Historic Market Growth, 2020-2025, $ Billion

Table 13: Global Thyroid Eye Disease (TED) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Table 14: Global Thyroid Eye Disease (TED) Market - TAM, US$ Billion, 2025

Table 15: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 16: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 17: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 18: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 19: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 20: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 21: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 22: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical and Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 23: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 24: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 25: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 26: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 27: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 28: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 29: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 30: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 31: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 32: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 33: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 34: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 35: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 36: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 37: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 38: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 39: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 40: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 41: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 42: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 43: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 44: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 45: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 46: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 47: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 48: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 49: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 50: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 51: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 52: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 53: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 54: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 55: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 56: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 57: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 58: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 59: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 60: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 61: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 62: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 63: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 64: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 65: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 66: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 67: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 68: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 69: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 70: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 71: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 72: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 73: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 74: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 75: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 76: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 77: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 78: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 79: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 80: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 81: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 82: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 83: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 84: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 85: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 86: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 87: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 88: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 89: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 90: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 91: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 92: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 93: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 94: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 95: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 96: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Table 97: Global Thyroid Eye Disease (TED) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Table 98: Global Thyroid Eye Disease (TED) Market - Company Scoring Matrix

Table 99: Viridian Therapeutics Inc Financial Performance

Table 100: Tourmaline Bio Inc Financial Performance

Table 101: Sling Therapeutics Inc Financial Performance

Table 102: Immunovant Inc Financial Performance

Table 103: Hoffmann-La Roche AG Financial Performance

Table 104: Global Thyroid Eye Disease (TED) Market, Competitive Benchmarking (In USD Billions)

Table 105: Global Thyroid Eye Disease (TED) Market, Competitive Dashboard

Table 106: Global Thyroid Eye Disease (TED) Market Size Gain ($ Billion), 2025 – 2030 By Country

Table 107: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Table 108: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Disease Severity, 2025 – 2030

Table 109: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

List Of Figures

Figure 1: Global Thyroid Eye Disease (TED) Market, Overview Of Key Products - Product Examples

Figure 2: Global Thyroid Eye Disease (TED) Market Attractiveness, Factor-Wise Evaluation

Figure 3: Global Thyroid Eye Disease (TED) Market, Supply Chain Analysis

Figure 4: Global Thyroid Eye Disease (TED) Market, Major Raw Material Providers

Figure 5: Global Thyroid Eye Disease (TED) Market, Major Resource Providers

Figure 6: Global Thyroid Eye Disease (TED) Market, Major Manufacturers (Suppliers)

Figure 7: Global Thyroid Eye Disease (TED) Market, Major Distributors And Channel Partners

Figure 8: Global Thyroid Eye Disease (TED) Market, Key Technologies & Future Trends

Figure 9: Global Thyroid Eye Disease (TED) Market, Major Trends

Figure 10: Global Thyroid Eye Disease (TED) Market, Major End Users

Figure 11: Global Thyroid Eye Disease (TED) Market, PESTEL (Political, Economic, Social, Technology, Environmental and Legal) Analysis

Figure 12: Global Thyroid Eye Disease (TED) Historic Market Growth, 2020-2025, $ Billion

Figure 13: Global Thyroid Eye Disease (TED) Forecast Market Growth, 2025-2030F, 2035F, $ Billion

Figure 14: Global Thyroid Eye Disease (TED) Market - TAM, US$ Billion, 2025

Figure 15: Global Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 16: Global Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 17: Global Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 18: Global Thyroid Eye Disease (TED) Market, Segmentation By Route Of Administration, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 19: Global Thyroid Eye Disease (TED) Market, Segmentation By End User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 20: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Medical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 21: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 22: Global Thyroid Eye Disease (TED) Market, Sub-Segmentation Of Combination Of Medical and Surgical, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 23: Global Thyroid Eye Disease (TED) Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 24: Global Thyroid Eye Disease (TED) Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 25: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 26: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 27: Asia-Pacific, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 28: China, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 29: China, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 30: China, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 31: India, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 32: India, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 33: India, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 34: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 35: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 36: Japan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 37: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 38: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 39: Australia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 40: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 41: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 42: Indonesia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 43: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 44: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 45: South Korea, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 46: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 47: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 48: Taiwan, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 49: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 50: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 51: South East Asia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 52: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 53: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 54: Western Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 55: UK, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 56: UK, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 57: UK, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 58: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 59: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 60: Germany, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 61: France, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 62: France, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 63: France, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 64: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 65: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 66: Italy, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 67: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 68: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 69: Spain, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 70: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 71: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 72: Eastern Europe, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 73: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 74: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 75: Russia, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 76: North America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 77: North America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 78: North America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 79: USA, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 80: USA, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 81: USA, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 82: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 83: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 84: Canada, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 85: South America, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 86: South America, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 87: South America, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 88: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 89: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 90: Brazil, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 91: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 92: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 93: Middle East, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 94: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Treatment Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 95: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Disease Severity, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 96: Africa, Thyroid Eye Disease (TED) Market, Segmentation By Drug Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

Figure 97: Global Thyroid Eye Disease (TED) Key Competitor Estimated Market Shares, 2024, Percentage (%)

Figure 98: Global Thyroid Eye Disease (TED) Market - Company Scoring Matrix

Figure 99: Viridian Therapeutics Inc Financial Performance

Figure 100: Tourmaline Bio Inc Financial Performance

Figure 101: Sling Therapeutics Inc Financial Performance

Figure 102: Immunovant Inc Financial Performance

Figure 103: Hoffmann-La Roche AG Financial Performance

Figure 104: Global Thyroid Eye Disease (TED) Market, Competitive Benchmarking (In USD Billions)

Figure 105: Global Thyroid Eye Disease (TED) Market, Competitive Dashboard

Figure 106: Global Thyroid Eye Disease (TED) Market Size Gain ($ Billion), 2025 – 2030 By Country

Figure 107: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Treatment Type, 2025 – 2030

Figure 108: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Disease Severity, 2025 – 2030

Figure 109: Global, Thyroid Eye Disease (TED) Market Size Gain ($ Billion), Segmentation By Drug Type, 2025 – 2030

Global Acute Care Telemedicine Market Forecast to Reach $66.59 Billion by 2029, Driven by 17.7% CAGR

2025–2029 Assistive Technology For Low Vision Market Outlook: Regional Trends and Growth Forecast

Global Biotechnology And Pharmaceutical Services Outsourcing Market Forecast to Reach $94.91 Billion by 2029, Driven by 7.2% CAGR

Cancer Treatment Facilities Market Revenue Outlook: Strategic Insights and Forecast to 2029

CAGR of 10.4% Projected for Catastrophic Antiphospholipid Syndrome Market From 2025 to 2029

Latest Market Developments in Clinical Risk Grouping Solution Industry: Forecast 2025–2029

2025–2029 Clinical Trial Investigative Site Network Market Outlook: Regional Trends and Growth Forecast

Future Demand and Leading Companies Shaping the Common Cold Market to 2029

Eye Melanoma Market Report 2026 - Global Outlook – By Site (Uvea, Sclera, Retina), By Diagnosis (Imaging, Biopsy, Eye Exam), By Treatment (Surgery, Radiation Therapy, Targeted Therapy, Immunotherapy, Other Treatment), By...

Thyroid Function Test Market Report 2026 - Global Outlook – By Test Type (Thyroid Stimulating Hormone (TSH), Triiodothyronine (T3), Thyroxine (T4), Free Triiodothyronine (FT3), Free Thyroxine (FT4)), By Indication (Hypot...

Thyroid Cancer Diagnostics Market Report 2026 - Global Outlook – By Technique Type (Imaging Test, Blood Test, Biopsy, Other Test Types), By Disease Type (Papillary Carcinoma, Follicular Carcinoma, Other Diseases), By End...

Optic Nerve Disorders Treatment Market Report 2026 - Global Outlook – By Treatment Type (Steroidal Therapy, Immunomodulators therapy, Other Treatment Types), By Indication (Glaucoma, Optic Neuritis, Optic Neuropathy, Con...

Ophthalmic Eye Dropper Market Report 2026 - Global Outlook – By Eye Dropper (Unidose Eye Dropper, Preserved Multi-Dose Eye Dropper, Preservative-Free Multi-Dose Eye Dropper), By Drug Type (Prescription Drugs, Over-The-Co...

Anemia And Other Blood Disorder Drugs Market Report 2026 - Global Outlook – By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Route of Administration (Oral, Injectab...

Ophthalmic Drugs Market Report 2026 - Global Outlook – By Type (Prescription Drugs, Over-The-Counter Drugs), By Class (Anti-Allergy, Anti-Inflammatory, Anti-Glaucoma, Other Classes), By Disease (Dry Eye, Eye Allergy, Gla...

Frequently Asked Questions

How big is the Thyroid Eye Disease (TED) Market?

The Thyroid Eye Disease (TED) market was valued at $2.29 billion in 2025, increased to $2.44 billion in 2026, and is projected to reach $3.12 billion by 2030.

What is the Thyroid Eye Disease (TED) market growth?

The global Thyroid Eye Disease (TED) market is expected to grow at a CAGR of 6.3% from 2026 to 2035 to reach $3.12 billion by 2035.

Who are the key players in Thyroid Eye Disease (TED) market?

Some Key Players in the Thyroid Eye Disease (TED) market Include, Viridian Therapeutics Inc, Tourmaline Bio Inc, Sling Therapeutics Inc, Immunovant Inc, Hoffmann‑La Roche AG, H Lundbeck A S, Alumis Inc, Changchun GeneScience Pharmaceutical Co Ltd, Minghui Pharmaceutical Inc, Amgen Inc, Crinetics Pharmaceuticals Inc, Ollin Biosciences Inc, Lycia Therapeutics Inc, Inflammasome Therapeutics Inc, Novartis Pharmaceuticals Corp, AdvanceCOR Inc, Worg Pharmaceuticals Inc, AV7 Limited, EVOQ Therapeutics Inc, ValenzaBio Inc, Regeneron Pharmaceuticals Inc, Santen Pharmaceutical Co Ltd, Sanofi SA, Alexion Pharmaceuticals Inc, Septerna Corporation .

What is the anticipated growth trend for the Thyroid Eye Disease (TED) market?

Major trend in this market includes: Amgen's TEPEZZA (Teprotumumab)A Breakthrough In Thyroid Eye Disease Treatment. For further insights on this market. request a sample here

Which region has the most growth potential in the Thyroid Eye Disease (TED) market?

North America was the largest region in the thyroid eye disease (TED) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the thyroid eye disease (ted) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.